Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NPI-001 vs Cysteamine in Cystinosis
NCT05994534Phase 2Completed
- Sponsor
- Nacuity Pharmaceuticals
- Start
- Oct 2023
- Primary completion
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of N-acetylcysteine amide in cystinosis, sponsored by Nacuity Pharmaceuticals. Started Oct 2023; status: completed.
02
Drugs
N-acetylcysteine amide
03
Conditions
cystinosis
Beyond the preview
Go deeper on NCT05994534.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05994534.